Buprenorphine sublingual tablet is prescribed to treat opioid use disorder in two phases: an induction phase to manage initial withdrawal symptoms and a maintenance phase for long-term treatment. You ...
Inconsistency in opioid dosing could be a risk factor for opioid overdose, according to a study published in JAMA Network Open. Researchers conducted the study at a Colorado-based integrated health ...
In a randomized trial, both 100-mg and 300-mg monthly maintenance doses of extended-release buprenorphine improved opioid abstinence in patients with high-risk opioid use, with no new safety signals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results